Parallel Processing
Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-05-15-2017
Volume 2017 eBook
Issue 1
Pages: s8-s12
Samsung BioLogics’ aggressive growth strategy begs the question: Are there lessons that US and European pharma might still learn from the electronics industry?
A look at how engineering-led companies from outside pharma are transforming biopharmaceutical contract services, and an interview with Samsung BioLogics’ vice president and head of business development, James Park, on the company’s history, culture, and plans.
Download
Pharmaceutical Technology’s 2017 Biologics and Sterile Drug Manufacturing eBook.
Articles in this issue
Clean, Disinfect, and Validate
Kill the Bioburden, Not the Biological Indicator
Cold Chain Logistics for Personalized Medicine: Dealing With Complexity
Ensuring the Biological Integrity of Raw Materials
Getting Biopharmaceutical Tech Transfer Right the First Time
Developing an Injectable Compound for a Dual- Chamber Delivery System
Case Study: Retrofitting Two New High-Purity Water Systems
Single-Use Bioreactors Have Reached the Big Time
Parallel Processing
Cost Considerations Drive Lean Technology in Biomanufacturing
Recent Videos
Related Content
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024Podcast
In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
